1. HBW Insight
  2. >>Wellness
  3. >>Policy & Regulation

CBD Drug Approval Not A Sign FDA Will Allow Its Use In Supplements

 
• By Malcolm Spicer

As a Schedule I controlled substance, CBD is not allowed by FDA for use in dietary supplements. Although CBD will be rescheduled by DEA to a less prohibitive Controlled Substances Act classification before GW Pharmaceuticals can launch its drug FDA approved June 25, its status for use in supplements won't change.

FDAEntrance_1200x675

FDA's approval of a cannabidiol-based drug might have the dietary supplement sector buzzing with anticipation about the agency potentially changing its policy prohibiting the ingredient's use in supplements.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Regulation

More from Policy & Regulation